Sandeep Chidambar Kulkarni Talaris Therapeutics, Inc. (TALS) insider trading activity

Sandeep Chidambar Kulkarni is CEO of Talaris Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TALS, which is worth approximately $0. The most recent transaction as insider was on Oct 28, 2025, when has been sold 30,387 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Sandeep Chidambar Kulkarni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 28 2025	SELL Sale (or disposition) back to the issuer	-	30,387 Reduced 100.0%	0 Common Stock
Oct 28 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	724,664 Reduced 95.98%	30,387 Common Stock
Oct 22 2025	BUY Exercise of conversion of derivative security	$199,996 $7.9 p/Share	25,316 Added 3.24%	755,051 Common Stock
Nov 17 2023	BUY Open market or private purchase	$67,960 $16.99 p/Share	4,000 Added 0.55%	729,735 Common Stock
Oct 26 2023	BUY Open market or private purchase	$61,250 $12.25 p/Share	5,000 Added 0.68%	725,735 Common Stock
Oct 24 2023	BUY Open market or private purchase	$49,662 $10.68 p/Share	4,650 Added 0.64%	720,735 Common Stock
Oct 19 2023	BUY Grant, award, or other acquisition	-	716,085 Added 50.0%	716,085 Common Stock

Also insider at

JATT-WT

JATT Acquisition Corp

Chief Executive Officer

SCK